Reuters logo
BRIEF-Hubei Jumpcan Pharma's prelim 2016 profit rises 35.8 pct y/y
February 6, 2017 / 10:51 AM / 8 months ago

BRIEF-Hubei Jumpcan Pharma's prelim 2016 profit rises 35.8 pct y/y

Feb 6 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd

* Says prelim 2016 net profit up 35.8 percent y/y at 932.46 million yuan ($135.91 million)

Source text in Chinese: bit.ly/2leK9MT

Further company coverage: ($1 = 6.8609 Chinese yuan renminbi) (Reporting by Beijing newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below